About Adipogen Life Sciences
Adipogen Life Sciences is a company based in San Diego (United States) founded in 2011. The company has 3 employees. Adipogen Life Sciences offers products and services including Antibodies, Proteins, and ELISA Kits. Adipogen Life Sciences operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and PrognomiQ, among others.
- Headquarter San Diego, United States
- Employees 3
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website adipogen.com/storeconfig/choose/store?destination=
- Social LinkedIn X
- Legal Name Adipogen
- Employee Count3
Products & Services of Adipogen Life Sciences
Adipogen Life Sciences offers a comprehensive portfolio of products and services, including Antibodies, Proteins, and ELISA Kits.
Monoclonal and polyclonal antibodies for scientific studies
Proteins with enhanced activity for research applications
Kits for detecting proteins in biological samples
People of Adipogen Life Sciences
1 people are tracked at Adipogen Life Sciences (1 in leadership); the tracked headcount is 3.
| Name | Role | Group |
|---|---|---|
Georges Chappuis | CEO | Leadership |
Complete people profiles for Adipogen Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Adipogen Life Sciences
Adipogen Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and PrognomiQ, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| prognomiq.com | 2020 | San Mateo, United States | $90.36M | 24 | Developer of tests for the detection and treatment of cancer and other diseases | |
| miltenyibiotec.com | 1989 | Bergisch Gladbach, Germany | – | 585 | Develops tools and products for research and clinical application | |
| devyser.com | 2004 | Stockholm, Sweden | $15.48M | – | Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders | |
| exonhit.com | 1997 | Paris, France | $65.46M | – | Fully integrated in vitro diagnostics company specializing in transplantation, infectious diseases and cancer diagnosis | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. |
Detailed competitors of Adipogen Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Adipogen Life Sciences
The website of Adipogen Life Sciences (adipogen.com) receives about 27.4K visits a month.
- Monthly visits27.4K
▲ 29.2% vs previous month
Websites whose visitors overlap most with Adipogen Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| abcam.com | 100% | 602.8K | #91,958 | View details | |
rpicorp.com | rpicorp.com | 100% | – | #1,292,794 | – |
enzolifesciences.com | enzolifesciences.com | 97% | – | – | – |
| genwaybio.com | 97% | – | – | View details | |
| cytoskeleton.com | 96% | 25.6K | #1,134,849 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 28 similar websites and full traffic analytics for Adipogen Life Sciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 28 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Adipogen Life Sciences
10 companies that operate in the same segment as Adipogen Life Sciences (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Adipogen Life Sciences
Adipogen Life Sciences was founded in 2011.
Adipogen Life Sciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Georges Chappuis is the current CEO of Adipogen Life Sciences.
Adipogen Life Sciences has 3 employees.
Adipogen Life Sciences was founded in 2011 and is based in San Diego, United States. Operations focus on the bioresearch reagents sector, where products are developed and manufactured for therapeutic areas including obesity, diabetes, immuno-oncology, inflammatory diseases, innate immunity, and antimicrobial resistance. Advanced ELISA kits, recombinant proteins, and antibodies form the core offerings, supported by chemical laboratories that isolate natural products and synthesize small molecules and rare antibiotics.
Adipogen Life Sciences's top competitors include Abcam, Sino Biological and PrognomiQ.
Adipogen Life Sciences offers Antibodies, Proteins, and ELISA Kits.
Adipogen Life Sciences operates through Adipogen.